PB2457: RUXOLITINIB AS TREATMENT IN PATIENTS WITH ACUTE AND CRONIC GRAFT-VERSUS-HOST DISEASE. REAL WORLD EVIDENCE

por José Jiménez Nájar, Francisco, Olivares Pérez, Belén, Aguirre Lora, Alicia, Romero Mata, Noelia, García Torres, Estefanía, Martín Calvo, Carmen
Publicado 2023

Evolving Risk Classifications in AML in a Real-Life Scenario: After Changes upon Changes, Is It More and More Adverse?

por Aparicio-Pérez, Clara, Prados de la Torre, Esther, Sanchez-Garcia, Joaquin, Martín-Calvo, Carmen, Martínez-Losada, Carmen, Casaño-Sanchez, Javier, Serrano-López, Juana, Serrano, Josefina
Publicado 2023

Mesenchymal Stromal Cells for Treating Steroid-Resistant Acute and Chronic Graft Versus Host Disease: A Multicenter Compassionate Use Experience

por Macías-Sánchez, María del Mar, Morata-Tarifa, Cynthia, Cuende, Natividad, Cardesa-Gil, Ana, Cuesta-Casas, María Ángeles, Pascual-Cascon, María Jesús, Pascual, Antonia, Martín-Calvo, Carmen, Jurado, Manuel, Perez-Simón, José Antonio, Espigado, Ildefonso, Garzón López, Sebastián, Carmona Sánchez, Gloria, Mata-Alcázar-Caballero, Rosario, Sánchez-Pernaute, Rosario
Publicado 2022